Cabozantinib/Nivolumab and Recombinant Human Hyaluronidase Regimen

**Semantic type:** Therapeutic or Preventive Procedure

**Definition:** A regimen consisting of cabozantinib, and nivolumab and recombinant human hyaluronidase that can be used in the treatment of renal cell carcinoma (RCC).

**Synonyms:** - Cabozantinib Plus Nivolumab and Recombinant Human Hyaluronidase - Cabozantinib-Nivolumab and Recombinant Human Hyaluronidase - Cabozantinib/Nivolumab and Hyaluronidase-nvhy - Cabozantinib/Nivolumab and Recombinant Human Hyaluronidase - Cometriq/Opdivo Qvantig